EVALUATION OF RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B LİGAND (RANKL) AND OSTEOPROTEGERIN (OPG) LEVELS IN PATIENTS DIAGNOSED WITH BRONCHIECTASIS AND OSTEOPOROSIS